Brookline, MA, United States of America

Jacob Vaya

This inventor holds 2 USPTO granted patents. Top assignee: Research, Incorporated. Active years: 1983-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacob Vaya. Retrieved from https://idiyas.com/inventor/jacob-vaya-bjmc74ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jacob Vaya: Innovator in Pharmaceutical Chemistry

Introduction

Jacob Vaya is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative approaches to drug synthesis.

Latest Patents

His latest patents include a method for the preparation of daunomycinone and its derivatives, utilizing the p-nitrobenzyloxy carbonyl group as a blocking group. This method is both regio- and stereospecific, highlighting his expertise in chemical synthesis. Another patent focuses on the synthesis of daunomycinone and its derivatives, further emphasizing his contributions to this area of research.

Career Highlights

Jacob Vaya is currently employed at Research, Incorporated, where he continues to advance his research in pharmaceutical chemistry. His work has been instrumental in developing new methods for drug preparation, which can have significant implications for medical treatments.

Collaborations

He has collaborated with notable colleagues, including Lakshminarayan Anathasubramanian and T Ross Kelly, who share his passion for innovation in the field.

Conclusion

Jacob Vaya's contributions to pharmaceutical chemistry through his patents and collaborative efforts demonstrate his commitment to advancing medical science. His innovative methods are paving the way for future developments in drug synthesis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…